详细信息
- ;地夫可特;地夫可特中间体;地那查特;X164;
- Deflazacort
- ;DEFLAZACORT;Deflazacort intermediate(D5);11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate;deflazacort intermediate;(4AR,4BS,5S,6AS,9AR,10AS,10BS)-6B-ACETYL-5-HYDROXY-4A,6A,8-TRIMETHYL-4A,4B,5,6,6A,6B,9A,10,10A,10B,11,12-DODECAHYDRO-9-OXA-7-AZA-PENTALENO[2,1-A]PHENANTHREN-2-ONE;2-(5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl)-2-oxoethyl acetate;2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate;(4aR,4bS,5S,6aS,9aR,10aS,10bS)-6b-acetyl-5-hydroxy-4a,6a,8-trimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-2-one;(11β,16β)-11-hydroxy-2-methyl-5β-H-progna-1,4-dieno[17,16-d]Oxazolo-3,20-dione;PREGNA-1,4-DIENE-11B-OL-17A,16A-D-2-METHYL-OXAZOLINE-3,20-DIONE;21-Deacetoxy Deflazacort;X164;
- InChI=1/C23H29NO4/c1-12(25)23-19(28-13(2)24-23)10-17-16-6-5-14-9-15(26)7-8-21(14,3)20(16)18(27)11-22(17,23)4/h7-9,16-20,27H,5-6,10-11H2,1-4H3/t16-,17-,18-,19+,20+,21-,22-,23?/m0/s1
- 1.39g/cm3
- 544.2°C at 760 mmHg
- 282.9°C
- 地夫可特 药物名称： 地夫可特 英文名称： Deflazacort 中文同义词: 地夫可特;地那查可特;地氟可特;(1LΒ,16Β)-21-乙酰氧基-11-羟基-2'-甲基-5'H-娠烷-1,4-二烯并[17,16-D]噁唑-3,20二酮;去氟可特 英文名称: 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate 分子式:C25H31NO6 分子量:441.52 CAS:14484-47-0 含量：98% 包装：1KG/听 外观性状,白色或类白色结晶粉末 用途：具有抗炎、抗过敏作用，相当于泼尼松龙10～20倍，用于肾上腺皮质机能减退、自身免疫性疾病、过敏性疾病及血液系统疾病等
- 包装：铝罐
- CAS NO：14484-47-0
产品规格：医药级
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。